Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

NMLSF

Rank in Stocks #31541
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Share Price
$0.0633
Last synced: 2026-11-16
Market Cap
$2.75M
Change (1 day)
0.00%
Change (1 year)
13.04%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Restart Life Sciences Corp. (NMLSF)

Category

Healthcare
EPS for Restart Life Sciences Corp. (NMLSF)
EPS as of June 2026 TTM: $-0.02
According to Restart Life Sciences Corp.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of 0.00, a decrease compared to its 2024 EPS of $0.01.
EPS history for Restart Life Sciences Corp. from 2005 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.02 -102.94%
2025 0.00 -102.94%
2024 $0.01 -116.24%
2023 $-0.06 -52.68%
2022 $-0.13 -30.12%
2021 $-0.19 -95.10%
2020 $-3.87 1,044.75%
2019 $-0.34 -62.07%
2018 $-0.89 33.55%
2017 $-0.67 -40.21%
2016 $-1.12 101.24%
2015 $-0.56 -83.07%
2014 $-3.28 384.34%
2013 $-0.68 -96.92%
2012 $-21.99 48.11%
2011 $-14.85 -49.80%
2010 $-29.58 -19.49%
2009 $-36.74 125.24%
2008 $-16.31 -32.61%
2007 $-24.20 214.39%
2006 $-7.70 71.87%
2005 $-4.48 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 -87,100.00%
US
$-7.08 39,233.33%
US
$-5.29 29,288.89%
AU
$21.56 -119,877.78%
NL
$12.73 -70,834.44%
BE

Questions about Restart Life Sciences Corp.'s earnings per share (EPS)

What is Restart Life Sciences Corp.'s earnings per share (EPS)?

Restart Life Sciences Corp.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.

What was Restart Life Sciences Corp.'s earnings per share (EPS) in 2025?

In 2025, Restart Life Sciences Corp.'s earnings per share (EPS) was 0.00, compared with $0.01 in 2024.

How has Restart Life Sciences Corp.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Restart Life Sciences Corp.'s earnings per share (EPS) was highest in 2024 ($0.01) and lowest in 2020 ($-3.87).

How does Restart Life Sciences Corp.'s earnings per share (EPS) compare with similar companies?

Restart Life Sciences Corp.'s earnings per share (EPS) ($-0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.